Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
McKesson
Baxter
Harvard Business School
Boehringer Ingelheim

Last Updated: August 17, 2022

Goserelin acetate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for goserelin acetate and what is the scope of freedom to operate?

Goserelin acetate is the generic ingredient in one branded drug marketed by Tersera and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Goserelin acetate has fifty patent family members in thirty-three countries.

There are four drug master file entries for goserelin acetate. Two suppliers are listed for this compound.

Summary for goserelin acetate
International Patents:50
US Patents:2
Tradenames:1
Applicants:1
NDAs:2
Drug Master File Entries: 4
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 38
Clinical Trials: 120
Patent Applications: 8,074
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in goserelin acetate?goserelin acetate excipients list
DailyMed Link:goserelin acetate at DailyMed
Recent Clinical Trials for goserelin acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gangnam Severance HospitalPhase 2
Seoul National UniversityPhase 2
Luye Pharma Group Ltd.Phase 1

See all goserelin acetate clinical trials

Medical Subject Heading (MeSH) Categories for goserelin acetate

US Patents and Regulatory Information for goserelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for goserelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 See Plans and Pricing See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 See Plans and Pricing See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 See Plans and Pricing See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 See Plans and Pricing See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 See Plans and Pricing See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for goserelin acetate

Country Patent Number Title Estimated Expiration
Canada 2398066 PROTECTION DE SURETE A FONCTIONNEMENT AUTOMATIQUE POUR SERINGUE (AUTOMATICALLY OPERABLE SAFETY SHIELD SYSTEM FOR SYRINGES) See Plans and Pricing
Denmark 1259274 See Plans and Pricing
Bulgaria 65506 See Plans and Pricing
European Patent Office 1259274 PROTECTION DE SURETE A FONCTIONNEMENT AUTOMATIQUE POUR SERINGUE (AUTOMATICALLY OPERABLE SAFETY SHIELD SYSTEM FOR SYRINGES) See Plans and Pricing
Russian Federation 2234341 АВТОМАТИЧЕСКИ СРАБАТЫВАЮЩАЯ ЗАЩИТНАЯ ОГРАЖДАЮЩАЯ СИСТЕМА ДЛЯ ШПРИЦЕВ (AUTOMATICALLY ACTUATED PROTECTIVE GUARDING SYSTEM FOR SYRINGES) See Plans and Pricing
Israel 150900 AUTOMATICALLY OPERABLE SAFETY SHIELD SYSTEM FOR SYRINGES See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Express Scripts
Colorcon
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.